Selected research
Market Structure
Global Systemic Antifungals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Systemic Antifungals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Systemic Antifungals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Systemic Antifungals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Systemic Antifungals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Systemic Antifungals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Systemic Antifungals include MSD, Zhuhai Ebang Pharmaceutical, Chiatai Tianqing, Xian-janssen, Novartis, Merck, Livzon Group Livzon Pharmaceutical Factory, Honz Pharmaceutical and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Systemic Antifungals market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Systemic Antifungals and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Systemic Antifungals revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Systemic Antifungals market size, projected growth trends, production technologies, key applications, and end-use industries.
Systemic Antifungals Segment by Company
MSD
Zhuhai Ebang Pharmaceutical
Chiatai Tianqing
Xian-janssen
Novartis
Merck
Livzon Group Livzon Pharmaceutical Factory
Honz Pharmaceutical
Pfizer
CR Pharma
Haisco Pharmaceutical
Medisan
Chengdu Brilliant Pharmaceutical
Bayer
Liposome Company
Gilead Sciences
Astellas Pharma
Systemic Antifungals Segment by Type
Injections
Oral
Systemic Antifungals Segment by Application
Clinic
Hospital
Drugstores
Others
Systemic Antifungals Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Systemic Antifungals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Systemic Antifungals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Systemic Antifungals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Systemic Antifungals in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Systemic Antifungals industry.
Chapter 3: Detailed analysis of Systemic Antifungals companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Systemic Antifungalsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injections
- Oral
Applications
- Clinic
- Hospital
- Drugstores
- Others
Companies covered
- MSD
- Zhuhai Ebang Pharmaceutical
- Chiatai Tianqing
- Xian-janssen
- Novartis
- Merck
- Livzon Group Livzon Pharmaceutical Factory
- Honz Pharmaceutical
- Pfizer
- CR Pharma
- Haisco Pharmaceutical
- Medisan
- Chengdu Brilliant Pharmaceutical
- Bayer
- Liposome Company
- Gilead Sciences
- Astellas Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Systemic Antifungals Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Injections
- 1.2.3 Oral
- 1.3 Market Analysis by Application
- 1.3.1 Global Systemic Antifungals Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Clinic
- 1.3.3 Hospital
- 1.3.4 Drugstores
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Systemic Antifungals Growth Trends by Region
- 1.5.1 Global Systemic Antifungals Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Systemic Antifungals Market Size by Region (2021-2026)
- 1.5.3 Systemic Antifungals Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Systemic Antifungals Market Dynamics
- 2.1 Systemic Antifungals Industry Trends
- 2.2 Systemic Antifungals Industry Drivers
- 2.3 Systemic Antifungals Industry Opportunities and Challenges
- 2.4 Systemic Antifungals Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Systemic Antifungals Revenue by Company (2021-2026)
- 3.2 Global Systemic Antifungals Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Systemic Antifungals Key Company Head office and Area Served
- 3.4 Global Systemic Antifungals Company, Product Type & Application
- 3.5 Global Systemic Antifungals Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Systemic Antifungals Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Systemic Antifungals Players Market Share by Revenue in 2025
- 3.6.3 2025 Systemic Antifungals Tier 1, Tier 2, and Tier 3
4 Systemic Antifungals Market by Type
- 4.1 Global Systemic Antifungals Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Systemic Antifungals Market Size by Type (2021-2032)
- 4.3 Global Systemic Antifungals Market Size Share by Type (2021-2032)
5 Systemic Antifungals Market by Application
- 5.1 Global Systemic Antifungals Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Systemic Antifungals Market Size by Application (2021-2032)
- 5.3 Global Systemic Antifungals Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 MSD
- 6.1.1 MSD Company Information
- 6.1.2 MSD Business Overview
- 6.1.3 MSD Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 MSD Systemic Antifungals Product Portfolio
- 6.1.5 MSD Recent Developments
- 6.2 Zhuhai Ebang Pharmaceutical
- 6.2.1 Zhuhai Ebang Pharmaceutical Company Information
- 6.2.2 Zhuhai Ebang Pharmaceutical Business Overview
- 6.2.3 Zhuhai Ebang Pharmaceutical Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Zhuhai Ebang Pharmaceutical Systemic Antifungals Product Portfolio
- 6.2.5 Zhuhai Ebang Pharmaceutical Recent Developments
- 6.3 Chiatai Tianqing
- 6.3.1 Chiatai Tianqing Company Information
- 6.3.2 Chiatai Tianqing Business Overview
- 6.3.3 Chiatai Tianqing Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Chiatai Tianqing Systemic Antifungals Product Portfolio
- 6.3.5 Chiatai Tianqing Recent Developments
- 6.4 Xian-janssen
- 6.4.1 Xian-janssen Company Information
- 6.4.2 Xian-janssen Business Overview
- 6.4.3 Xian-janssen Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Xian-janssen Systemic Antifungals Product Portfolio
- 6.4.5 Xian-janssen Recent Developments
- 6.5 Novartis
- 6.5.1 Novartis Company Information
- 6.5.2 Novartis Business Overview
- 6.5.3 Novartis Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Novartis Systemic Antifungals Product Portfolio
- 6.5.5 Novartis Recent Developments
- 6.6 Merck
- 6.6.1 Merck Company Information
- 6.6.2 Merck Business Overview
- 6.6.3 Merck Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Merck Systemic Antifungals Product Portfolio
- 6.6.5 Merck Recent Developments
- 6.7 Livzon Group Livzon Pharmaceutical Factory
- 6.7.1 Livzon Group Livzon Pharmaceutical Factory Company Information
- 6.7.2 Livzon Group Livzon Pharmaceutical Factory Business Overview
- 6.7.3 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Product Portfolio
- 6.7.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments
- 6.8 Honz Pharmaceutical
- 6.8.1 Honz Pharmaceutical Company Information
- 6.8.2 Honz Pharmaceutical Business Overview
- 6.8.3 Honz Pharmaceutical Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Honz Pharmaceutical Systemic Antifungals Product Portfolio
- 6.8.5 Honz Pharmaceutical Recent Developments
- 6.9 Pfizer
- 6.9.1 Pfizer Company Information
- 6.9.2 Pfizer Business Overview
- 6.9.3 Pfizer Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Pfizer Systemic Antifungals Product Portfolio
- 6.9.5 Pfizer Recent Developments
- 6.10 CR Pharma
- 6.10.1 CR Pharma Company Information
- 6.10.2 CR Pharma Business Overview
- 6.10.3 CR Pharma Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 CR Pharma Systemic Antifungals Product Portfolio
- 6.10.5 CR Pharma Recent Developments
- 6.11 Haisco Pharmaceutical
- 6.11.1 Haisco Pharmaceutical Company Information
- 6.11.2 Haisco Pharmaceutical Business Overview
- 6.11.3 Haisco Pharmaceutical Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Haisco Pharmaceutical Systemic Antifungals Product Portfolio
- 6.11.5 Haisco Pharmaceutical Recent Developments
- 6.12 Medisan
- 6.12.1 Medisan Company Information
- 6.12.2 Medisan Business Overview
- 6.12.3 Medisan Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Medisan Systemic Antifungals Product Portfolio
- 6.12.5 Medisan Recent Developments
- 6.13 Chengdu Brilliant Pharmaceutical
- 6.13.1 Chengdu Brilliant Pharmaceutical Company Information
- 6.13.2 Chengdu Brilliant Pharmaceutical Business Overview
- 6.13.3 Chengdu Brilliant Pharmaceutical Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Chengdu Brilliant Pharmaceutical Systemic Antifungals Product Portfolio
- 6.13.5 Chengdu Brilliant Pharmaceutical Recent Developments
- 6.14 Bayer
- 6.14.1 Bayer Company Information
- 6.14.2 Bayer Business Overview
- 6.14.3 Bayer Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Bayer Systemic Antifungals Product Portfolio
- 6.14.5 Bayer Recent Developments
- 6.15 Liposome Company
- 6.15.1 Liposome Company Company Information
- 6.15.2 Liposome Company Business Overview
- 6.15.3 Liposome Company Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Liposome Company Systemic Antifungals Product Portfolio
- 6.15.5 Liposome Company Recent Developments
- 6.16 Gilead Sciences
- 6.16.1 Gilead Sciences Company Information
- 6.16.2 Gilead Sciences Business Overview
- 6.16.3 Gilead Sciences Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Gilead Sciences Systemic Antifungals Product Portfolio
- 6.16.5 Gilead Sciences Recent Developments
- 6.17 Astellas Pharma
- 6.17.1 Astellas Pharma Company Information
- 6.17.2 Astellas Pharma Business Overview
- 6.17.3 Astellas Pharma Systemic Antifungals Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Astellas Pharma Systemic Antifungals Product Portfolio
- 6.17.5 Astellas Pharma Recent Developments
7 North America
- 7.1 North America Systemic Antifungals Market Size (2021-2032)
- 7.2 North America Systemic Antifungals Market Size by Type
- 7.2.1 North America Systemic Antifungals Market Size by Type (2021-2026)
- 7.2.2 North America Systemic Antifungals Market Size by Type (2027-2032)
- 7.2.3 North America Systemic Antifungals Market Share by Type (2021-2032)
- 7.3 North America Systemic Antifungals Market Size by Application
- 7.3.1 North America Systemic Antifungals Market Size by Application (2021-2026)
- 7.3.2 North America Systemic Antifungals Market Size by Application (2027-2032)
- 7.3.3 North America Systemic Antifungals Market Share by Application (2021-2032)
- 7.4 North America Systemic Antifungals Market Size by Country
- 7.4.1 North America Systemic Antifungals Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Systemic Antifungals Market Size by Country (2021-2026)
- 7.4.3 North America Systemic Antifungals Market Size by Country (2027-2032)
- 7.4.4 North America Systemic Antifungals Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Systemic Antifungals Market Size (2021-2032)
- 8.2 Europe Systemic Antifungals Market Size by Type
- 8.2.1 Europe Systemic Antifungals Market Size by Type (2021-2026)
- 8.2.2 Europe Systemic Antifungals Market Size by Type (2027-2032)
- 8.2.3 Europe Systemic Antifungals Market Share by Type (2021-2032)
- 8.3 Europe Systemic Antifungals Market Size by Application
- 8.3.1 Europe Systemic Antifungals Market Size by Application (2021-2026)
- 8.3.2 Europe Systemic Antifungals Market Size by Application (2027-2032)
- 8.3.3 Europe Systemic Antifungals Market Share by Application (2021-2032)
- 8.4 Europe Systemic Antifungals Market Size by Country
- 8.4.1 Europe Systemic Antifungals Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Systemic Antifungals Market Size by Country (2021-2026)
- 8.4.3 Europe Systemic Antifungals Market Size by Country (2027-2032)
- 8.4.4 Europe Systemic Antifungals Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Systemic Antifungals Market Size (2021-2032)
- 9.2 China Systemic Antifungals Market Size by Type
- 9.2.1 China Systemic Antifungals Market Size by Type (2021-2026)
- 9.2.2 China Systemic Antifungals Market Size by Type (2027-2032)
- 9.2.3 China Systemic Antifungals Market Share by Type (2021-2032)
- 9.3 China Systemic Antifungals Market Size by Application
- 9.3.1 China Systemic Antifungals Market Size by Application (2021-2026)
- 9.3.2 China Systemic Antifungals Market Size by Application (2027-2032)
- 9.3.3 China Systemic Antifungals Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Systemic Antifungals Market Size (2021-2032)
- 10.2 Asia Systemic Antifungals Market Size by Type
- 10.2.1 Asia Systemic Antifungals Market Size by Type (2021-2026)
- 10.2.2 Asia Systemic Antifungals Market Size by Type (2027-2032)
- 10.2.3 Asia Systemic Antifungals Market Share by Type (2021-2032)
- 10.3 Asia Systemic Antifungals Market Size by Application
- 10.3.1 Asia Systemic Antifungals Market Size by Application (2021-2026)
- 10.3.2 Asia Systemic Antifungals Market Size by Application (2027-2032)
- 10.3.3 Asia Systemic Antifungals Market Share by Application (2021-2032)
- 10.4 Asia Systemic Antifungals Market Size by Country
- 10.4.1 Asia Systemic Antifungals Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Systemic Antifungals Market Size by Country (2021-2026)
- 10.4.3 Asia Systemic Antifungals Market Size by Country (2027-2032)
- 10.4.4 Asia Systemic Antifungals Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Systemic Antifungals Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Systemic Antifungals Market Size by Type
- 11.2.1 South America, Middle East & Africa Systemic Antifungals Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Systemic Antifungals Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Systemic Antifungals Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Systemic Antifungals Market Size by Application
- 11.3.1 South America, Middle East & Africa Systemic Antifungals Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Systemic Antifungals Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Systemic Antifungals Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Systemic Antifungals Market Size by Country
- 11.4.1 South America, Middle East & Africa Systemic Antifungals Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Systemic Antifungals Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Systemic Antifungals Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Systemic Antifungals Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst